Meet Erin

Hear from Erin, one of our Access Specialists, on how she may help your patients enrolled in SAJAZIR™ (icatibant) injection access their treatment as efficiently as possible.

SAJAZIR (icatibant) injection is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.1

Once an enrollment form for SAJAZIR has been submitted, our Access Specialists may help with:

Insurance coverage support

  • Securing a Benefit Verification
  • Prior Authorization Assistance
  • Appeals Support

Accessing medication

  • Providing a free supply of SAJAZIR through our Bridge Program*, so your patients can begin therapy immediately
  • Setting up specialty pharmacy routing
  • Prescription Renewal Support

Co-pay assistance

  • Your commercially insured patients enrolled in SAJAZIR may pay as little as $0 – 96% of patients paid a $0 co-pay in 20252

“I absolutely love being able to make a difference in someone’s life and ensure that they’re getting the medication they need.”

Contact us if you have any questions about SAJAZIR or available patient support

A friendly, familiar team is waiting here at Cycle Vita, for you and your patients, at every step.
Cycle Vita Logo With Strapline
Cycle Vita Logo With Strapline
A friendly, familiar team is waiting here at Cycle Vita, for you, at every step.

+1 (888) 360-8482


*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at 888-360-8482.

References

1. SAJAZIR™ (icatibant) Injection. Prescribing Information. Cycle Pharmaceuticals Limited.
2. Data on File: Ref-00101.